Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study
Purpose - - The aim of this subset analysis was to determine if bortezomib treatment is associated with increased incidence of varicella-zoster virus (VZV) reactivation in patients with relapsed multiple myeloma (MM). - - Patients and Methods - - Incidence of herpes zoster was evaluated in 663 pa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[October 10 2008]
|
| In: |
Journal of clinical oncology
Year: 2008, Jahrgang: 26, Heft: 29, Pages: 4784-4790 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2007.14.9641 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2007.14.9641 Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.2007.14.9641 
|
| Verfasserangaben: | Asher Chanan-Khan, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Rachel Neuwirth, Kenneth C. Anderson, and Paul G. Richardson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1786135078 | ||
| 003 | DE-627 | ||
| 005 | 20230428030402.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220114s2008 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2007.14.9641 |2 doi | |
| 035 | |a (DE-627)1786135078 | ||
| 035 | |a (DE-599)KXP1786135078 | ||
| 035 | |a (OCoLC)1341436873 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Chanan-Khan, Asher A. A. |e VerfasserIn |0 (DE-588)1011454394 |0 (DE-627)704777940 |0 (DE-576)343226901 |4 aut | |
| 245 | 1 | 0 | |a Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study |c Asher Chanan-Khan, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Rachel Neuwirth, Kenneth C. Anderson, and Paul G. Richardson |
| 264 | 1 | |c [October 10 2008] | |
| 300 | |b 1 Diagramm | ||
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online ahead of print at www.jco.org on August 18, 2008 | ||
| 500 | |a Gesehen am 14.01.2022 | ||
| 520 | |a Purpose - - The aim of this subset analysis was to determine if bortezomib treatment is associated with increased incidence of varicella-zoster virus (VZV) reactivation in patients with relapsed multiple myeloma (MM). - - Patients and Methods - - Incidence of herpes zoster was evaluated in 663 patients with relapsed MM from the phase III APEX trial comparing single-agent bortezomib with high-dose dexamethasone. - - Results - - Bortezomib was associated with a significantly higher incidence of herpes zoster compared with dexamethasone treatment (13%, 42 of 331 v 5%, 15 of 332; P = .0002). Most herpes zoster infections were grade 1/2; incidences of grade 3/4 events (1.8% v 1.5%) and infections considered serious adverse events (1.5% v 0.9%) were similar between treatment arms, and no herpes zoster-related deaths occurred. Neither the time to onset of the herpes event nor the patients’ absolute lymphocyte counts at baseline differed significantly between arms. VZV reactivation was the only herpes viral event noted to be significantly elevated in the bortezomib treatment group compared with the dexamethasone treatment group (P = .0002). The incidence of non-VZV-related herpes viral infections was comparable between arms. No additional risk factors for herpes zoster reactivation were identified. - - Conclusion - - Further studies are needed to explain these observations and their implications; however, for patients treated with bortezomib or bortezomib-containing regimens, the risk of VZV reactivation should be monitored and routine use of antiviral prophylaxis considered. | ||
| 700 | 1 | |a Sonneveld, Pieter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schuster, Michael W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stadtmauer, Edward A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Facon, Thierry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Harousseau, Jean-Luc |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ben-Yehuda, Dina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lonial, Sagar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Reece, Donna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Neuwirth, Rachel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anderson, Kenneth C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Richardson, Paul G. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 26(2008), 29, Seite 4784-4790 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study |
| 773 | 1 | 8 | |g volume:26 |g year:2008 |g number:29 |g pages:4784-4790 |g extent:7 |a Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study |
| 856 | 4 | 0 | |u https://doi.org/10.1200/JCO.2007.14.9641 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://ascopubs.org/doi/10.1200/JCO.2007.14.9641 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220114 | ||
| 993 | |a Article | ||
| 994 | |a 2008 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 9 | ||
| 999 | |a KXP-PPN1786135078 |e 4035815829 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study","title_sort":"Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX study"}],"note":["Published online ahead of print at www.jco.org on August 18, 2008","Gesehen am 14.01.2022"],"origin":[{"dateIssuedKey":"2008","dateIssuedDisp":"[October 10 2008]"}],"id":{"doi":["10.1200/JCO.2007.14.9641"],"eki":["1786135078"]},"recId":"1786135078","relHost":[{"title":[{"title":"Journal of clinical oncology","title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedKey":"1983","dateIssuedDisp":"1983-"}],"pubHistory":["1.1983 -"],"disp":"Analysis of herpes zoster events among Bortezomib-treated patients in the phase III APEX studyJournal of clinical oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"313116962","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["313116962"],"zdb":["2005181-5"],"issn":["1527-7755"]},"corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"language":["eng"],"part":{"issue":"29","text":"26(2008), 29, Seite 4784-4790","pages":"4784-4790","year":"2008","extent":"7","volume":"26"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}]}],"physDesc":[{"extent":"7 S.","noteIll":"1 Diagramm"}],"name":{"displayForm":["Asher Chanan-Khan, Pieter Sonneveld, Michael W. Schuster, Edward A. Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Rachel Neuwirth, Kenneth C. Anderson, and Paul G. Richardson"]},"person":[{"display":"Chanan-Khan, Asher A. A.","family":"Chanan-Khan","role":"aut","given":"Asher A. A."},{"family":"Sonneveld","display":"Sonneveld, Pieter","given":"Pieter","role":"aut"},{"family":"Schuster","display":"Schuster, Michael W.","given":"Michael W.","role":"aut"},{"role":"aut","given":"Edward A.","family":"Stadtmauer","display":"Stadtmauer, Edward A."},{"family":"Facon","display":"Facon, Thierry","role":"aut","given":"Thierry"},{"role":"aut","given":"Jean-Luc","family":"Harousseau","display":"Harousseau, Jean-Luc"},{"given":"Dina","role":"aut","family":"Ben-Yehuda","display":"Ben-Yehuda, Dina"},{"display":"Lonial, Sagar","family":"Lonial","given":"Sagar","role":"aut"},{"role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"given":"Donna","role":"aut","display":"Reece, Donna","family":"Reece"},{"display":"Neuwirth, Rachel","family":"Neuwirth","role":"aut","given":"Rachel"},{"role":"aut","given":"Kenneth C.","display":"Anderson, Kenneth C.","family":"Anderson"},{"family":"Richardson","display":"Richardson, Paul G.","role":"aut","given":"Paul G."}],"language":["eng"]} | ||
| SRT | |a CHANANKHANANALYSISOF1020 | ||